Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Industry: Healthcare

Cosmetic Dentistry from an Expert Ensures Treatments Meet Patient Needs, says Dr. Sahar Verdi of Dental Specialists of California

Leave a comment


Dr. Sahar Verdi of Dental Specialists of California

Some patients may have limited amounts of time to get their teeth looking the way they want but skilled dentists will understand how to best accommodate those situations


THOUSAND OAKS, Calif. (PRWEB)

A June 8 article on Harper’s Bazaar Arabia reports on a plethora of tips for brides-to-be, and patients in general, who are seeking teeth whitening treatments. The article notes that those wanting optimal results should not wait until right before their big event as the best results generally come from multiple treatments that require a few weeks to achieve their full impact. The article notes that this is not to say that professional teeth whitening treatment won’t offer immediate results – rather, it’s that patients will achieve their best results if they work with their dentist over several visits as this can deliver the right shade across all their teeth as well as a healthy look and feel. Board-certified Periodontist and Cosmetic Dentist Sahar Verdi, D.D.S. of Dental Specialists of California largely agrees, saying that professional-grade teeth whitening treatments vary and that while multiple treatments do have a higher chance of delivering the results that patients ultimately want, patients can sometimes achieve dramatic results with a single treatment. She adds that deciding factors include the skill of the dentist as well as how advanced the treatment is.

Dr. Verdi says that professional teeth whitening often comes in multiple forms, including both in-office and take-home kits. Both options work very well for the majority of patients, she adds, while combining treatments may even further enhance final results. On the topic of patients who may be concerned about how long it takes for a procedure to achieve its maximum impact, such as soon-to-be-brides, Dr. Verdi notes that, provided patients have realistic expectations.

Beyond a dentist’s abilities and access to advanced treatment, Dr. Verdi notes that a patient’s lifestyle and dental care will also play a significant role in how well a whitening treatment may work. Dr. Verdi says that skilled dentists will be able to figure out which approach, or approaches, best suit a patient through careful examination. Even if it turns out that veneers or other prosthetics are necessary, there’s almost always an effective teeth whitening solution for patients and it’s simply up to the dentist to figure out what that is.

Dr. Verdi adds that, regardless of patients’ dental issues or timeframes, there’s always a solution she can provide to ensure all patients can finally get the healthy and beautiful smiles they dream of.

Readers seeking additional information on Dr. Sahar Verdi or Dental Specialists of California can visit her website at https://dentalspecialistsofca.com/ or call her office at (805) 370-7171.

Share article on social media or email:

Health

Dr. Buckingham Co-Authors New Fat Grafting and Facelift Surgery Article

Leave a comment



AUSTIN, Texas (PRWEB)

Edward D. Buckingham’s newly published article “Incorporating Fat Grafting with Facelift Surgery, When, How, and Where” recently appeared on Facial Plastic Surgery Clinics of North America, a series based on medical, scientific, and technical research in regards to the latest techniques in surgical techniques. Dr. Buckingham is a graduate of the University of Texas Medical Branch of Galveston. He is double board-certified by The American Board of Otolaryngology and the American Board of Facial Plastic and Reconstructive Surgery.

Dr. Buckingham is the author of numerous articles published in medical journals and has delivered presentations on the subjects of otolaryngology and facial plastic and reconstructive surgery. In his recent article, Dr. Buckingham discusses facial aging and the loss of volume in bone, skin, and soft tissue.

He writes that “Historically, aging of the face is simplistically thought to occur because of persistent gravitational effects on the face resulting in ptotic tissue, and therefore, rejuvenation of the face requires surgical lifting of those tissues. Although certainly there are a multitude of facial surgical procedures to accomplish these goals, the complete picture of facial aging is more complicated, and surgical lifting alone fails to address completely the goal of reversing facial aging.”

Age-related characteristics of facial aging that are easily recognizable as the decades pass include skin changes. Wrinkles, age spots, and spider veins, as well as subtle shadows, are early features of facial aging brought on by changes in volume that occur as a result of skeletal remodeling as well as in the soft tissues.

Dr. Buckingham states that one of the most common surface-shadowing locations is right below the eye. The shadowing is generally referred to as tear trough deformity or orbital groove. Some individuals also suffer from under eye fat deposits, causing the eyes to appear puffy.

Facial fat grafting is a procedure in which fat is removed from one part of the body and moved to the face. The result is a fresher and more youthful appearance. “Just as skincare and laser resurfacing can contribute to the overall improvement in facial aging, so does volume replacement assist in correcting the subtle shadows that contribute to the recognition and appearance of the face in later decades.” Replacing facial volume can play an important role in facial rejuvenation and can be successfully added to traditional procedures involving elevation of sagging or drooping features.

Buckingham Center is a medical center providing both cosmetic and reconstructive procedures. Non-surgical procedures include acne scarring, chemical peels, diamond glow, facial spider veins, birthmarks, chest rejuvenation, frown lines, and chin liposuction. They also perform injectables, liquid rhinoplasty, laser treatments, and rosacea treatments. Surgical procedures include facelifts, lip, neck, and forehead lifts, skin cancer, facial trauma, rhinoplasty, lip enhancement, chin and cheek augmentation, and facial fat transfer.

All procedures are preceded by an in-depth consultation. Each patient is given a variety of options that address his or her aesthetic concerns, budget, and time commitment to recovery. Digital images are taken during the consultation. With the use of imaging software, the photos are altered, allowing patients to see the results of the procedure under discussion.

Dr. Buckingham is currently accepting new patients and offering virtual consultations. To schedule an appointment, please call the office at 512-401-2500. You can also use the online form to contact the office. For more information on the specific services offered by Dr. Buckingham and his team at Buckingham Center for Facial Plastic Surgery, please visit their website.

Share article on social media or email:

Industry: Healthcare

David N. Maine, M.D., Becomes President & CEO of Mercy Health Services

Leave a comment


Dr. David Maine, President & CEO, Mercy Health Services

Dr. David Maine, President & CEO, Mercy Health Services

“Dr. Maine is uniquely qualified to bolster and further expand Mercy’s award-winning clinical programs, enhancing Mercy’s singular position as an independent, Catholic health system with statewide reach,” said Sister Helen Amos, RSM, Executive Chair of the Mercy Health Services Board of Trustees.


BALTIMORE, Md. (PRWEB)

David N. Maine, M.D. is the new President & CEO of Mercy Health Services (MHS), effective July 1st, 2020. In January 2020, the Mercy Health Services Board of Trustees named Dr. Maine as Mercy’s future President & CEO following Thomas R. Mullen’s decision to retire after 28 years of successful service. Dr. Maine’s appointment marks the first time a physician has led the hospital and health system in its 145-year history. Mercy Health Services is the parent of Mercy Medical Center, a university-affiliated hospital in Downtown Baltimore founded by the Sisters of Mercy in 1874.

“As a longtime Mercy physician leader, Dr. Maine is uniquely qualified to bolster and further expand Mercy’s award-winning clinical programs, enhancing Mercy’s singular position as an independent, Catholic health system with statewide reach,” said Sister Helen Amos, RSM, Executive Chair of the Mercy Health Services Board of Trustees. “For more than a decade at Mercy, Dr. Maine has consistently demonstrated clinical and business excellence, compassion for our patients, and a deep personal commitment to our mission and values. He’s exactly the right leader at the right time for Mercy.”

“I am honored and humbled to be selected by the Board of Trustees to follow in Tom’s footsteps as President & CEO of Mercy Health Services,” Dr. David Maine said. “As a result of Sister Helen’s and Tom’s leadership over the years, Mercy is blessed with outstanding physicians, providers, nurses, staff and a strong team of executive leaders all committed to moving Mercy forward for many years to come,” Dr. Maine said. “In addition, Mercy has established itself as the premier physician-friendly health system in the region where physicians feel the freedom to practice medicine in the way they know is best for their patients and that has translated to high-quality care with our patients at the center of everything we do.”

“Mercy has become a strong regional health system through the creation of Centers of Excellence led by renowned physicians who developed nationally-recognized clinical programs and by building a large network of high-quality primary and specialty care sites, downtown and around the beltway,” Mr. Mullen said. “The selection of Dr. Maine is a natural extension of Mercy’s physician-driven culture and our mission to serve patients throughout the region within a community of compassionate care. I wish him the very best as he leads Mercy into the future.”

Dr. David Maine, 43, has served as Executive Vice President for Mercy Health Services since October 2019, responsible for all MHS operations, overseeing the Medical Center, specialty and primary care physician networks, and Mercy affiliates. Prior to assuming the Executive Vice President role, he was Executive Vice President of Mercy’s Physician Enterprise, focusing on the growth of its physician network. Dr. Maine has also served as President of Medical Staff; as Senior Vice President of Clinical Transformation, leading Mercy’s efforts to launch the SurgCenter of Towson; and since 2007, as Medical Director of The Center for Interventional Pain Medicine at Mercy, perennially earning distinction as a Baltimore magazine “Top Doctor”.

Dr. Maine lives in Pikesville, Maryland with his wife, also a physician, and their two children. He was born the son of Jewish-Iraqi refugees who fled Iraq for Europe in 1972 due to the ongoing persecution of the religious minority. With the assistance of the Hebrew Immigrant Aid Society, an international refugee aid organization, Dr. Maine’s family eventually immigrated to the United States, settling in Rochester, New York in 1974. (Learn more about Dr. David Maine’s story).

Dr. Maine attended local public schools in Irondequoit, New York. He then matriculated at the University of Rochester School of Arts and Science and the University of Rochester School of Medicine graduating in 2002 with Alpha Omega Alpha honors. He completed his residency in Anesthesiology and his fellowship in Interventional Pain Medicine at The Johns Hopkins Hospital and is Board Certified in Anesthesiology and Pain Medicine.

“With Dr. Maine taking the helm, I have no doubt Mercy will continue its special commitment to the poor and underserved and remain a shining beacon of light and hope for our City,” said Baltimore Archbishop William Lori. “We are grateful for Sister Helen Amos’ continuing service as Executive Chair of the Board of Trustees and Mercy’s ongoing promise to remain an independent, locally-governed health system, fully committed to its Catholic identity.”

“Mercy is well-positioned under the leadership of Dr. David Maine as the new President and CEO to carry forward Mercy’s mission and values as inspired by the life of our founder, Catherine McAuley,” said Sister Pat Coward, RSM, Health Ministry Liaison for the Sisters of Mercy of the Americas, South Central Community. “We look forward to working with Dr. Maine to continue to further our health care ministry for the people of Baltimore.”

Founded in 1874 by the Sisters of Mercy, Mercy Medical Center is a university-affiliated hospital with a national reputation for women’s health care. For more information about Mercy, visit http://www.mdmercy.com and MDMercyMedia on FACEBOOK and TWITTER.

###

Share article on social media or email:

Health

Mediaplanet Joins Forces with Leaders in the Fight Against Neurological Disorders for Upcoming USA TODAY Campaign

Leave a comment


News Image

The campaign will spotlight the most promising diagnostics and treatment options in neurological health, which will collectively reduce the emotional, physical and financial burden of these disorders, improve patient outcomes and quality of life.


NEW YORK (PRWEB)

Mediaplanet has joined forces with key leaders in the fight against Neurological Disorders for its upcoming campaign. The campaign is set to launch on September 29th within USA Today and digitally to build awareness surrounding the millions of Americans living with a neurological disorder as well as shine light on their care takers. The print platform will be a 12-16 page tabloid-style insert within USA Today with the print platform living on Mediaplanet’s healthcare content hub, http://www.futureofpersonalhealth.com

A major focus within this campaign will be on “Fighting Alzheimer’s”. Alzheimer’s is the sixth-leading cause of death in the U.S. Not only does this disease have devastating effects on the patient and his or her family, it’s also the nation’s most expensive condition to treat and care for.

This campaign will gather experts such as American Stroke Association, Alzheimer’s Association, American Brain Foundation, Brain Injury Association of America, and Dr. Oz to speak on its effects.

Insight from these leaders will run within the print and digital campaigns and will be amplified through Mediaplanet and all participants’ social channels.

This campaign will give both patients and healthcare professionals the power of knowledge by spotlighting the most promising diagnostics and treatment options in neurological health, which will collectively reduce the emotional, physical and financial burden of these disorders, improve patient outcomes and quality of life.

Mediaplanet teams are currently on-boarding participants to the campaign. Participants can come in the form of editorial partners or branded sponsorship partners. For more information on this campaign and how to get involved, please reach out to Executive Publisher Victoria Borkowski or Partnership and Distribution Manager Jordan Hernandez at the below contact information.

Let’s fight this fight together!

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Press Contacts:

Jordan Hernandez – Partnership and Distribution Manager

Jordan.hernandez@mediaplanet.com

Victoria Borkowski – Executive Publisher of Neurological Disorder Campaign

Victoria.borkowski@mediaplanet.com

Share article on social media or email:

Health

BluePearl Pet Hospital Finds Alarming Increase in Parvovirus Cases Amid COVID-19

Leave a comment


BluePearl Specialty + Emergency Pet Hospital Logo

“As invaluable sources of emotional support as well as sentinels and potential vectors of infectious disease, it is vital pets receive all preventative care vaccines, and owners adhere to the timing requirements of those vaccines,” remarked Dr. James Barr, Chief Medical Officer.


TAMPA, Fla. (PRWEB)

BluePearl Specialty and Emergency Pet Hospital has observed an alarming increase in the number of parvovirus cases and hospitalizations during the COVID-19 pandemic. Analysis of data from BluePearl’s more than 90 pet hospitals showed a 70% increase in the number of parvovirus cases relative to ER cases in 2020 as compared to the same time periods in the past five years (2015 to 2019).

Parvovirus, or parvo, is a highly contagious, potentially deadly disease that attacks the gastrointestinal tracts of infected canines. While puppies are most at risk for contracting parvo, any unvaccinated or partially vaccinated dog can contract the disease through dog-to-dog contact and contact with contaminated stool, environments, or people. If left untreated, most parvo deaths occur within 48 to 72 hours. However, survival rates can approach 90% with proper treatment.

“We are in the very early stages of analyzing this data; looking for possible causes of the increase and determining what the implications are for this and other preventable companion animal diseases,” remarked James Barr, DVM, DACVECC, Chief Medical Officer, BluePearl Pet Hospital. “Parvo outbreaks pose a serious threat to our canine friends but skipping routine vaccinations could also put human health at risk through the possibility of rabies exposure. As invaluable sources of emotional support as well as sentinels and potential vectors of infectious disease, it is vital pets receive all preventative care vaccines, and owners adhere to the timing requirements of those vaccines.”

Amid the COVID-19 outbreak, many people turned to animals for companionship. This resulted in significant fostering and adoption of shelter animals. Some of these shelter animals may have been released without completion of their vaccination series. Stay at home orders also prompted a trend in people spending more time outdoors, which could have increased environmental exposure (i.e. dog parks). Other possible causes for the uptick include disruptions in the timing of or prevention of puppies receiving full vaccine series, resulting in incomplete immunity, and financial hardships, such as job loss, preventing or delaying owners from seeking routine vaccinations.

“If the U.S. continues to see COVID-19 cases increase or a second wave, this may exacerbate these trends and further harm our pets,” explained Lenore Bacek, DVM, MS, DACVECC, Clinical Programs Manager, BluePearl Pet Hospital. “To prevent further increase, and to ensure this does not happen again, veterinary hospitals and related businesses must continue to be recognized as essential services. Owners must also be vigilant not to bring their dogs or puppies to dog parks or other high traffic areas until fully vaccinated. As we delve deeper into this data, we hope to better understand the complexities of this parvovirus outbreak, as well as shine light on the value veterinary medicine brings to public health.”

While dogs and puppies may begin showing signs of parvovirus between three to ten days after exposure, they are often contagious before visible symptoms. If you suspect your pet has parvovirus, immediately isolate your pet and contact your primary care veterinarian.

About BluePearl Specialty and Emergency Pet Hospital

Founded in 1996, BluePearl is one of the largest specialty and emergency veterinary practices in the U.S. today. BluePearl has more than 90 hospitals in 26 states that together employ 5,900+ Associates, including 1,160+ veterinarians, 1,650+ veterinary technicians, and 3,000+ other professionals. Each year, our compassionate teams provide high-quality care for over one million pets and their families. BluePearl clinicians also participate in clinical studies to discover new treatments and procedures that improve pet health. As part of the Mars Veterinary Health family of brands, BluePearl is committed to its purpose—A BETTER WORLD FOR PETS®—because pets make a better world for us. Learn more at https://bluepearlvet.com/.

Share article on social media or email:

Health

OnlineMedEd Raises $5M From Physician Networks Across the Nation

Leave a comment


The funding comes at a time when OnlineMedEd is leveraging its education, technology and clinical expertise to support health care professionals beyond medical school in the fight against COVID-19.


AUSTIN, Texas (PRWEB)

OnlineMedEd, a digital healthcare learning platform, today announced a $5M financing round, raised from more than 20 physicians, founders, and partners of some of the largest physician-owned firms in the United States. The funds will be used to support the expansion of their platform beyond medical school to provide high-quality educational content for the over 60 million healthcare professionals across the globe – in specialties ranging from nursing to physician assistants to MD’s and DO’s.

Today, OnlineMedEd is the clinical learning platform of choice for a broad spectrum of healthcare learners. Over 86% of medical students in the United States are currently using OnlineMedEd to gain the knowledge needed not just to excel in Board exams, but also in clinical practice. In addition to being used by individual med students, OnlineMedEd’s suite of products are institutionally used by over 50 universities nationally, and many more around the world.

“Our purpose is to change how medical education is delivered to bring up the quality and performance of the entire healthcare industry,” said Jamie Fitch, CEO of OnlineMedEd. “This investment round, raised from highly qualified physicians, further validates the broad demand for OnlineMedEd in the healthcare profession. We’re excited to leverage our investors’ clinical expertise, professional networks, and business resources as we grow into new markets beyond medical school.”

The funding comes at a time when OnlineMedEd is leveraging its education, technology and clinical expertise to support health care professionals beyond medical school in the fight against COVID-19. The company recently launched a Crash Course in Medicine, a suite of 48 free online video lessons aimed at helping redeployed medical professionals get up-to-speed on the medical knowledge they need to confidently provide care in today’s environment.

OnlineMedEd has seen an acceleration of adoption since this launch. Prior to the pandemic, they had over 200,000 monthly active users; today, they have over 350,000 monthly active users. In April 2020, the company recorded 27 million minutes of watched video, a more than 100% increase over their healthy baseline of 13 million minutes / month.

“The innovation and reach of OnlineMedEd’s comprehensive medical curriculum is exceeded only by the goodwill of their educational mission,” says Glenn C. Robinson, M.D., past President of Austin Gastroenterology, P.A. and one of the investors in OnlineMedEd. “The ease and accessibility of its integrative learning tools will be embraced by students and educators alike as a welcomed and timely addition to the traditional learning experience. As an investor, I envision OnlineMedEd’s complete solution as merely the DNA base pairs to replicate for the future of all professional education.”

In addition to Crash Course, OnlineMedEd provides key learning modules including:


  • CaseX – an online experience that provides students with the critical practice of applying clinical reasoning with real patients, real questions, and real experience. It features immersive, interactive videos of real-life patients and supplemented with test results, images, and other case details.

  • Intern Bootcamp – a program that provides incoming residents with decades’ worth of wisdom, skills, tips, and tricks to ensure they are fully prepared for the beginning of their career.

OnlineMedEd was founded in 2014 and is headquartered in Austin, TX. The digital learning platform is currently used in 191 countries.

To learn more about OnlineMedEd, please visit: https://onlinemeded.org.

About OnlineMedEd

OnlineMedEd is a digital healthcare learning platform whose mission is to change how medical education is approached, delivered and learned by healthcare students and institutions alike.

Used in 191 countries and by more than 86% of clinical medical students domestically, the OnlineMedEd learning platform combines technology, education, and data-driven insights to create a comprehensive and personalized experience for its learners, making learning faster, easier, and more reliable. All material is peer-reviewed and developed by physician educators with one goal in mind – making students into better providers.

For more information, visit http://www.onlinemeded.org.

Share article on social media or email:

Health

Bridget Gauer, Joins Cognosante as Senior Vice President of Strategy

Leave a comment


“Bridget is a proven leader with a strong track record at large federal agencies, including the NIH and Department of Health and Human Services. She will be an excellent addition to our leadership team as she supports the company’s overall growth process from pursuit to execution.”


SPRINGFIELD, Va. (PRWEB)

Cognosante today announced the appointment of Bridget Gauer as the company’s Senior Vice President of Strategy.

Gauer joins Cognosante after spending several years at the National Institutes of Health (NIH) Information Technology Acquisition and Assessment Center (NITAAC) where she served as the Director. In this role, Gauer set the strategic vision for the NIH GWAC program, which consists of three contract vehicles: CIO-SP3, CIO-SP3 Small Business, and CIO-CS.

“This is a vital time for Cognosante, and the addition of this role positions the company to reach the next level of size and scope. Bridget is a proven leader with a strong track record in acquisition management at large federal agencies, including the NIH and Department of Health and Human Services. She will be an excellent addition to our leadership team as she supports the company’s overall growth process from pursuit to execution,” says Michele Kang, Founder and Chief Executive Officer.

Gauer has over 25 years of acquisition and leadership expertise. Prior to joining NITAAC, she served as the Division Director of Contracts for the Health and Human Services (HHS) Assistant Secretary of Preparedness and Response and the Acting Director for the Acquisition Program Support Division with the Office of Acquisition Management, Contracts, and Grants Office. She has worked in several leadership positions within the Federal Acquisition community including with the Federal Communication Commission and the Department of Homeland Security. Gauer holds a B.S. in Recreation, an MBA, and an M.A. in National Security and Strategic Studies from the Naval War College.

“I am incredibly excited to join Cognosante. This role provides an opportunity for me to apply my government and leadership experience in a new capacity while focusing on strategy and growth. Together with my colleagues, I look forward to supporting Cognosante’s mission and enhancing their relationships with additional government agencies,” quoted Gauer.

About Cognosante

Cognosante provides technology solutions and business process outsourcing to Federal, state, and local government health agencies as well as social services and defense agencies. The company has more than a decade of experience working with States and the Federal government, developing, managing, and executing large, complex health information programs. Its expertise includes Medicaid, Medicare, military and Veterans’ health, the health insurance marketplace, data standards and analytics, cybersecurity, biometrics, and modular system development and integration.

Visit cognosante.com for more information.

Share article on social media or email:

Industry: Healthcare

Comprehensive Database of Clinical Diagnostic Equipment Now Available

Leave a comment


Kalorama Information logo

The COVID-19 pandemic has put a spotlight on clinical laboratories in the U.S. and we have vastly increased our coverage of the critical molecular diagnostic segment.


ARLINGTON, Va. (PRWEB)

Kalorama Information, part of Science and Medicine Group, announced the release of the latest edition of the Kalorama Clinical Diagnostics MasterFile containing information on more than 42,000 pieces of equipment installed at more than 5,300 hospitals and testing sites facilities in the U.S.

The product is designed to help in vitro diagnostic (IVD) manufacturers find customers, verify the data their sales team are providing, and locate weak points in the competition. Kalorama Clinical Diagnostics MasterFile is the most comprehensive database of the installed base of clinical diagnostic instruments in the U.S. The ongoing survey of hospitals across the country continuously updates data on more than 42,000 instruments, including manufacturer, model, number installed, year installed, and department location. It covers every major modality, including:

  • Blood Gas Analyzers

  • Chemistry

  • Coagulation

  • Hematology

  • Immunoassay

  • Integrated Chem/Immuno

  • Mass Spectrometry

  • Microbiology AST ID

  • Microbiology Blood Culture

  • Molecular Diagnostics

  • Next-Generation Sequencing

  • Urinalysis Analyzers (automated)

Key demographics such as address, population served, budget, and key points of contact are also included. The information provided by laboratory managers at U.S. diagnostic sites is continuously gathered by phone and an online reporting system. Newly added this year is the ability to search based on planned purchases in 2020 providing hundreds of actionable leads.

“The COVID-19 pandemic has put a spotlight on clinical laboratories in the U.S. and we have vastly increased our coverage of the critical molecular diagnostic segment,” said Tamara Smith, VP, Clinical Diagnostics. “Our database can be linked to sources of IDN data so that you can understand the resources of an entire IDN to supplement and verify information collected by your sales team.”

More information is available at: https://kaloramainformation.com/product/clinical-diagnostics-masterfile/

About Science and Medicine Group

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Our clients, including some of the top Fortune 500 companies in the world, use our business intelligence, market research and publications, and marketing platforms to grow their businesses globally.

Share article on social media or email:

Health

The top treatments of 2020 at Pulse Light Clinic

Leave a comment



LONDON (PRWEB)

From hair removal methods that will make your skin smoother to the A-lister facial whose 30-minute treatment could give you Hollywood-worthy skin, here are four treatments that will give you a kick start to post lockdown. Senior Consultant, Lucy Dawe gives further information about the most in demand treatments of 2020.

Laser Hair Removal

Start investing in your hair removal and the planet. Lockdown is over and it’s time to stop going through endless plastic razors and monthly waxing appointments? Laser hair removal helps with reduction of ingrown hairs and pigmentation. With up to 90% hair reduction you can see an increase in smoother skin. Pulse Light Clinic have laser technology which allows safe and effective treatment for all skin types.

The cost: from £65 with discounted packages.

The time: from 15 minutes depending on the area.

CoolSculpting

Get in your best shape and shift that stubborn fat with the number 1 FDA cleared fat-freezing treatment, CoolSculpting. See real results with up to 27% fat reduction in 3 months, it’s clinically proven and the before and afters are impressive! The treatment can be used on the chin, arms, abdomen, back fat, flanks, thighs, and results can be seen in as little as one treatment.

The cost: from £400 dependant on the size of the area.

The time: from 35 minutes. A free consultation with a body transformation plan is required.

Hydrafacial

A non-surgical facial rejuvenation treatment for acne scars and to boost collagen. The Hydrafacial has 3 steps Cleanse and Peel with a gentle exfoliation and resurfacing, Extract and Hydrate with the vacum extraction and moisturiser and Fuse and Protect with a lymphatic drainage and LED light. In short, it helps a multitude of skin issues for all skin types. Don’t believe us? The “A-Lister” line up for this treatment to prepare their skin for events like weddings, award shows, premieres and the Met Gala. .

The cost: from £180 with discounted packages.

The time: From 30 minutes.

EMSculpt

Whether you would like a ‘bigger booty’, toned arms, toned calves or that six-pack you’ve always dreamed of, we are here to help you cheat your way there!!! A reduction of -19% fat with a course and +16% increase in muscle mass. Introducing EMSCULPT machine, uses a unique electromagnetic field that passes through the skin to impact muscle tissue as well as destroying fat all in the same 30 minute session at the same time!

The cost: from £3000 for 4 treatments.

The time: 30 minutes per treatment.

Share article on social media or email:

Health

MOBILTEX launches the RMU1 LITE, bringing large-scale IIoT capabilities and advanced remote monitoring to pipeline Cathodic Protection systems

Leave a comment


MOBILTEX RMU1 LITE for CP Test Stations

Benefits are realized in many areas including safety, operational efficiency, and providing engineers access to a much richer and complete dataset in order to improve CP performance and ultimately better protect assets and infrastructure. Marc Bracken, Mobiltex CEO


CALGARY, Alberta (PRWEB)

The CorTalk RMU1 LITE is equipped with essential, fit-for-purpose functionality derived from the field-proven CorTalk RMU1 device. These simplified features make the RMU1 LITE an ideal solution to cost-effectively achieve high volume deployment to CP test stations and empower corrosion engineers and pipeline integrity operations to realize the powerful benefits of IIoT (Industrial Internet of Things) remote monitoring.

With a network of battery-powered CorTalk RMU1 LITE devices transmitting data by cellular or satellite networks, pipeline operators can effectively eliminate the need to physically visit CP test stations to obtain annual pipe-to-soil potential measurements. Many of these test stations are in remote, difficult-to-reach sites and traveling to them can expose technicians to hazards in isolated locations, mountainous regions, swamps, airport or train right-of-ways, high voltage infrastructure, and more. As regulations continue to expand (or evolve), more and more pipeline operators will be under increasing scrutiny to prove their infrastructure is adequately protected – more frequent pipe-to-soil measurements can be a key tool to prove regulatory compliance.

The CorTalk RMU1 LITE offers user-selectable intervals, greatly enhancing the amount of pipe-to-soil data that is automatically collected as compared to manually obtained annual pipe-to-soil potential readings. Pipeline operators can take advantage of this capability to collect multiple measurements throughout the year, providing a richer data set to understand seasonal variations or short-term operating irregularities that can negatively impact CP system performance. This flexibility also provides a measure of future-proofing since the RMU1 LITE will be able to meet regulatory requirements for more frequent data collection that may come into force.

“There are millions of CP test stations installed on critical pipeline assets throughout North America and much of the data is still collected just once a year by field technicians in a time-consuming, manual process,” said Marc Bracken, CEO. “MOBILTEX developed the CorTalk RMU1 LITE to bring pipe-to-soil potential measurement into the IIoT world with a fit-for-purpose feature set and an affordable price for large-scale deployment. Benefits are realized in many areas including safety, operational efficiency, and providing engineers access to a much richer and complete dataset in order to improve CP performance and ultimately better protect assets and infrastructure. We are confident that pipeline operators will quickly see tremendous value with an investment in CorTalk RMU1 LITE devices.”

The CorTalk RMU1 LITE also provides unique measurement capabilities that can significantly enhance CP operation and optimization. During an interruption event, the device takes an instant-off potential measurement, meeting the data requirements for annual level of protection surveys and further reinforcing the operational insights provided by more granular measurements.

The RMU1 LITE offers the unique capability to obtain separate pipe-to-soil potential measurements from two connected reference cells. This allows technicians to compare the results and validate whether the reference cells are functioning properly.

Data that is transmitted by the RMU1 LITE, and other MOBILTEX remote monitoring devices, is received and stored by CorView, a powerful cloud-based software platform. CorView can be accessed from any location, using any web-enabled device, to access measurement data, create trending graphs and generate reports. Technicians can also configure CorView to automatically send alerts if measurements received from the RMU1 LITE are outside of set thresholds or if data is not received at scheduled intervals. CorView’s data repository and functions are entirely hosted and supported by MOBILTEX, which means no special software or IT support is ever required to access its powerful capabilities.

Please visit http://www.mobiltex.com/rmu1-lite to learn more.

About MOBILTEX

Over 30 years of cathodic protection system monitoring innovation, over 200 major organizations across North America and around the globe, and over one-hundred thousand miles of pipeline assets protected – the MOBILTEX hardware/software platform solutions are redefining the cathodic protection system monitoring industry. As our reputation grows, we continue to invest and expand our patented IIoT technologies while leveraging 5G cellular and satellite communications across our portfolio. MOBILTEX is widely recognized in the industry for innovation, reliability, and our world-class service and support. THIS IS MOBILTEX. WE’RE THERE.

Share article on social media or email: